Bone cells: resorption and mineralization

Who it is for

• Pharmaceutical and biotech groups developing anti-resorptive or bone-anabolic drugs who want an unloaded cell model
• Academic bone and mechanobiology labs studying how osteoclasts and osteoblasts sense gravity
• Space agency human research programmes working on astronaut bone loss countermeasures
• Bone-graft and resorbable biomaterial companies testing how cells resorb or mineralize their scaffolds
• Dental and craniofacial research groups using dentin or bone substrates

What earlier flights found

How LELP-1 runs it

Sample. Two arms in one cassette (our design). Arm A, resorption: an osteoclast precursor line (for example murine RAW 264.7) or human CD14+ monocytes, seeded onto devitalized bovine cortical bone slices or dentin discs, plus calcium-phosphate-coated clear wells for in-flight imaging. Arm B, early mineralization: MC3T3-E1 pre-osteoblasts on clear tissue-culture wells. Container. Large bay 24-well cassette: 8 wells bone/dentin slices (Arm A), 4 wells calcium-phosphate-coated clear wells (Arm A, imaged), 8 wells clear plastic (Arm B), 4 wells cell-free slices and coated wells as background controls. Gas-permeable lids inside the sealed BSL-2 bay. Launch. Cryopreserved (cells in freezing medium in the -80 C passive cassette); slices and coated wells launch dry and sterile; media and reagents in reservoirs. Labile factors (RANKL, M-CSF, ascorbate) need 4 C storage while the bay runs at 37 C (see needs). Light and gas. Dark except during imaging. No CO2: HEPES-buffered alpha-MEM based media, sealed bay air headspace through gas-permeable lids.

1. day 0

   Launch and orbit insertion. Cells stay frozen in the passive cassette; bay held at 4 C.

2. day 1

   Automated thaw, dilution and wash; seed Arm A onto slices and coated wells, Arm B onto clear wells. Bay ramps to 37 C. Brightfield image of all clear wells to record seeding density.

3. day 2

   Medium exchange. Arm A: add RANKL (plus M-CSF if primary monocytes). Arm B: growth medium. Collect first supernatant aliquot from each well.

4. day 4

   Arm A medium plus RANKL refreshed. Arm B switched to osteogenic medium (ascorbic acid and beta-glycerophosphate) once near confluence. Daily brightfield imaging begins for fusion and spreading.

5. day 6

   Medium exchange in both arms; supernatant aliquot saved for collagen telopeptide (for example CTX-I) and TRAP5b assays after return. Imaging: count multinucleated cells on coated wells.

6. day 8

   Medium exchange; add calcein to Arm B medium to label newly deposited mineral. Supernatant aliquot saved. Brightfield imaging of coated wells for cleared areas; calcein fluorescence on Arm B.

7. day 10

   Medium exchange; supernatant aliquot saved. Full imaging pass of all clear wells; optional robotic-arm transfer to the central 40x fluorescence microscope.

8. day 11

   Final supernatant collection. Half of each arm fixed with buffered paraformaldehyde (for TRAP, actin, pit and mineral staining); the other half covered with an RNA-stabilizing reagent. Bay ramps to 4 C straight away.

9. day 12

   Fixative replaced with buffer at 4 C. Bay stays at 4 C through de-orbit, re-entry and splashdown.

The payload module, in CAD

Every item in the module sheet, drawn and packed into the large bay deck by deck. The back face mates with the bay: blind-mate connector, and a cold wall against the bay's thermoelectric block. The front face carries Dexter-L's grapple fixture, and the fluid lines run down a channel just behind it. What you load before launch is marked blue in the configurator's payload guide.

CAD generated by cad/build_modules.py (CadQuery, OpenCascade kernel) from the catalog's module items: concept geometry, not a released design. Standard parts keep their real formats; the rest are sized from their catalog mass. The front panel and grapple fixture are left off in the 3-D view and are in the STEP.

• The XY stage travels 96.5 x 57.9 mm, so every one of the 24 wells reaches the objective; with the stage the imaging stack is 232 x 151 mm, which sets the module's depth budget.
• Reagent volumes the catalog does not state are split evenly from 75 % of the reservoir item's mass. The waste bag holds the spent medium and washes; fixatives and stabilisers stay in the wells and come home.
• Fluid pack: 8 reagent bags in 3 layers (196 x 94 x 69 mm), every port on a front edge.
• The waste bag lies under the reagent bags and fills the room they free: they hold 825 mL, it needs 309 mL.
• The catalog gives 0.30 kg for structure and containment; as an aluminium box that is a 0.14 mm skin on 0.09 kg of posts and shelves. Thin: the bay rails have to carry the launch loads, or the module needs more structure mass.
• The grapple fixture stands 26 mm proud of the front panel, into the bay opening; everything else is inside the bay envelope.

Ground control

An identical flight-model module and 24-well cassette, filled from the same cell vials, slice batch and reagent lots, runs on the ground in a spare bay. It replays the flight temperature log and the same fluidics and imaging timeline, offset by a few hours so it can follow the actual flight events. Fixed and stabilized samples are handled and shipped the same way. A synchronous 1 g in-flight centrifuge control, as flown on FOTON-M3 (OCLAST), Bion-10 and IML-2, is the best way to separate microgravity from launch and radiation effects but is not part of the standard bay.

Coming home

All wells are fixed or RNA-stabilized in orbit on day 11, so no live cells need to survive re-entry. Keep the cassette at 4 C from day 11 through recovery and courier transfer (about 20 min after splashdown plus 1-2 days to the lab), which can total about 3 to 6 days. The 168 h limit is our estimate: the RNA-stabilizing reagent maker rates RNA as stable for 1 month at 4 C, but supernatant proteins are less certain. If the total will exceed 168 h, put stabilized samples and supernatants on dry ice or at -80 C on the recovery ship. Fixed slices tolerate longer at 4 C once fixative is replaced with buffer.

Limits of this flight

• Bone and dentin slices are opaque, so resorption pits on them cannot be seen with the inverted microscope in flight; only the calcium-phosphate-coated clear wells give in-flight resorption data, and their contrast in brightfield may be weak until they are stained after return.
• Mature mineralized nodules from osteoblast lines usually need longer culture than a 14-day mission allows (our assumption), so Arm B gives early mineralization and differentiation markers, not mature mineralized matrix.
• The flight evidence for reduced mineralization comes from fetal mouse bone organ cultures, not from osteoblast monolayers; Arm B tests whether a similar effect shows up in a simpler cell model.
• Cells must be thawed and seeded in orbit; thaw and attachment losses add variability, and the protocol must be proven on the ground first.
• Without the optional centrifuge, launch loads, radiation at 550 km and handling in the bay cannot be fully separated from microgravity; the ground control covers only temperature and timeline.
• Isolated cells on slices lack osteocytes, blood supply, hormones and mechanical loading, so results show direct cell responses, not whole-skeleton bone loss.
• No crew means no slice replacement, no fresh-reagent preparation and no extra fixation time points beyond those planned in the reservoirs.
• Microgravity is about 1e-4 to 1e-3 g while the robotic arm moves; arm moves should be avoided during the key fusion and resorption days.
• Samples reach the lab 1-2 days after splashdown, so no live-cell work after return is possible; everything is fixed or stabilized in orbit.